An automated method to study the rapid intramolecular transacylation of drug acyl glucuronides using Cyclic Ion Mobility Spectrometry-Mass Spectrometry

Significance of the Topic

Formation of acyl glucuronides (AGs) via glucuronidation is a key drug metabolism pathway but carries safety concerns due to potential hepatotoxicity and market withdrawal of some compounds. Monitoring intramolecular transacylation among AG isomers provides insight into metabolite stability and risk assessment. Rapid and automated methods are essential to capture fast rearrangement kinetics in drug development and regulatory testing.

Goals and Overview of the Study

This work aims to develop an automated, real‐time approach for measuring the rate of intramolecular transacylation of 1-β-O acyl glucuronides using Cyclic Ion Mobility Spectrometry–Mass Spectrometry (cIM-MS). By integrating incubation and analysis within a single workflow, the method seeks to calculate reaction half‐lives without lengthy liquid chromatography (LC) development.

Methodology and Instrumentation

Sample Preparation and Incubation:

• Naproxen acyl glucuronide (NAG) at 100 µM in 10 mM ammonium acetate buffer.
• Pre‐incubation at room temperature for 2 h to generate a mixture of isomers for method setup.
• Real‐time incubation at 37 °C conducted in the LC autosampler with periodic aliquots delivered by flow injection analysis (FIA).

Analytical Platform:

• Waters SELECT SERIES Cyclic IMS coupled to a quadrupole‐ion mobility–time‐of‐flight (Q-IMS-Tof) mass spectrometer.
• Negative‐ion electrospray ionization.
• Five passes of ions through the cyclic ion mobility cell to enhance separation based on collision cross section (CCS).

Prediction and Calibration:

• CCS values predicted using CCS OnDemand 2.0 suggested baseline separation of the 1-O NAG form from its 2, 3 and 4-O isomers.

Results and Discussion

Ion mobility arrival time distributions (ATDs) demonstrated clear differentiation between the parent 1-β-O NAG and its transacylated isomers within minutes. Flow injection traces tracked the decay of the 1-β-O form (m/z 405 [M–H]–) and concurrent rise of downstream isomers. Kinetic analysis delivered half‐life calculations in real time, contrasting with conventional LC-MS methods that require ~15 min per run. This high‐resolution IMS approach resolved isomeric peaks without chromatographic separation, enabling sub‐minute temporal resolution.

Benefits and Practical Applications

• Significant reduction in analysis time compared to traditional LC-MS assays.
• Automated incubation and sampling minimize manual intervention and enhance throughput.
• Direct CCS‐based separation avoids extensive chromatographic method development.
• Applicable for safety profiling of AGs in drug discovery and early toxicology studies.

Future Trends and Opportunities

Advances may include applying the cIM-MS workflow to a broader range of acyl glucuronides and other labile metabolites. Further improvements in ion mobility resolution and integration with high‐throughput screening platforms could accelerate safety assessment pipelines. Machine learning–driven CCS prediction and real‐time data processing are potential directions to enhance predictive toxicology.

Conclusion

An automated Cyclic IMS–MS method has been established for rapid, real‐time monitoring of AG transacylation kinetics. The workflow eliminates reliance on lengthy LC separations, delivering high‐resolution isomer separation and reliable half‐life determinations. This approach holds promise for streamlined metabolite stability studies in pharmaceutical research.

Used Instrumentation

• Waters SELECT SERIES Cyclic IMS.
• Q-IMS-Tof mass spectrometer.
• Waters LC autosampler configured for 37 °C incubation and flow injection.

References

1. Higton D., Wilson I.D., Vissers J.P.C., Plumb R.S. Anal Chem. 2021, 93(20):7413–7421.
2. Broeckling C. et al. J Am Soc Mass Spectrom. 2021, 32:661–669.